|Mr. Francis R. Amato||CEO & Director||866.52k||N/A||1964|
|Mr. Joseph P. Errico||Co-Founder, Chief Science & Strategy Officer, Principal Investor & Director||685.19k||N/A||1969|
|Dr. Peter S. Staats||Sr. Exec. Advisor of Medical & Gov. Affairs||463.73k||N/A||1964|
|Mr. Steven M. Mendez||Founder & CTO||N/A||N/A||1961|
|Mr. Brian M. Posner||CFO & Corp. Sec.||N/A||N/A||1962|
electroCore, Inc., a bioelectronic medicine company, engages in developing a range of patient-administered non-invasive vagus nerve (VNS) stimulation therapies for the treatment of various conditions in neurology, rheumatology, and other fields. The company is developing gammaCore, a prescription-only non-invasive VNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, which is a handheld delivery system for multi-year use prescribed on a monthly basis. The company was founded in 2005 and is headquartered in Basking Ridge, New Jersey.
electroCore, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.